🇺🇸 FDA
Patent

US 10781450

Antisense molecules and methods for treating pathologies

granted A61PA61P21/00A61P21/04

Quick answer

US patent 10781450 (Antisense molecules and methods for treating pathologies) held by Sarepta Therapeutics, Inc. expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P21/00, A61P21/04